Status:

COMPLETED

Pharmacology of Insulin Injected With Jet-Injection

Lead Sponsor:

Radboud University Medical Center

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The purpose of this study is to compare the pharmacological profile of insulin administered with jet-injection with that of insulin injected with a conventional insulin pen.

Eligibility Criteria

Inclusion

  • Age 18-50 years
  • Body-mass index 18-28 kg/m2
  • Blood pressure \<160/90 mmHg
  • Stable glycaemic control with HbA1c 6.5-9.0% (for patients with type 1 diabetes mellitus)
  • Duration of diabetes \>1 year (for patients with type 1 diabetes mellitus)

Exclusion

  • Inability to provide informed consent
  • Chronic use of medication other than oral contraceptives or thyroid hormone replacement therapy (with stable euthyroidism for at least 3 months)
  • Chronic use of medication other than insulin or low-dose angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) treatment (for patients with type 1 diabetes mellitus)
  • Type 2 diabetes in first-degree relatives (for healthy subjects)
  • History of a major cardiovascular disease event (myocardial infarction, stroke, symptomatic peripheral artery disease, coronary bypass surgery, percutaneous coronary or peripheral artery angioplasty)
  • Pregnancy
  • Macroalbuminuria, i.e. urinary albumin excretion \>200 microg/min in collected urine sample or urinary albumin-to-creatinine ratio \>300 mg/g in spot urine sample (for patients with type 1 diabetes mellitus)
  • Symptomatic diabetic neuropathy (for patients with type 1 diabetes mellitus)
  • Proliferative diabetic retinopathy (a history of proliferative retinopathy that was successfully treated with laser coagulopathy is not an exclusion criterion) (for patients with type 1 diabetes mellitus)

Key Trial Info

Start Date :

November 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2010

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00983775

Start Date

November 1 2009

End Date

November 1 2010

Last Update

August 11 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboud University Nijmegen Medical Centre

Nijmegen, P.O. Box 9101, Netherlands, 6500 HB